Literature DB >> 7541711

Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen.

J A Francisco1, L K Gilliland, M R Stebbins, N A Norris, J A Ledbetter, C B Siegall.   

Abstract

We have constructed anti-CD40 immunotoxins consisting of the single chain Fv (sFv) region of the anti-human CD40 mAb G28-5 fused to a truncated form of Pseudomonas exotoxin, PE40. CD40 is an integral membrane glycoprotein found on the surface of B-lineage cells, including lymphomas and leukemias, as well as certain carcinomas. Two forms of the immunotoxin were constructed, one with the light chain variable (VL) region of the sFv preceding the heavy chain variable region (VH) [G28-5 sFv(VL-VH)-PE40] and the second with the sFv in the opposite orientation [G28-5 sFv(VH-VL)-PE40]. Although both forms of G28-5 sFv-PE40 specifically bound to CD40 in ELISAs, the binding of G28-5 sFv(VL-VH)-PE40 was > 10-fold higher. A number of malignant B- and T-cell lines were screened for CD40 expression and susceptibility to G28-5 sFv(VL-VH)-PE40. All of the B-lineage cells tested were CD40 positive and sensitive to the anti-CD40 immunotoxin, with EC50s ranging from 2.5-70 ng/ml, whereas none of the T cell leukemias or lymphomas were antigen positive or were affected by the immunotoxins. Consistent with the antigen-binding results, the VL-VH immunotoxin was > 10-fold more cytotoxic than the VH-VL immunotoxin. The anti-CD40 single-chain immunotoxin fusion protein G28-5 sFv(VL-VH)-PE40 represents a potent and specific cytotoxic agent for the elimination of normal and transformed B-lineage cells expressing CD40.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541711

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  4 in total

1.  CD40 is a prognostic marker in primary cutaneous malignant melanoma.

Authors:  J J van den Oord; A Maes; M Stas; J Nuyts; S Battocchio; A Kasran; M Garmyn; I De Wever; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

2.  T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation.

Authors:  F Mach; U Schönbeck; R P Fabunmi; C Murphy; E Atkinson; J Y Bonnefoy; P Graber; P Libby
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

3.  Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice.

Authors:  M Coelho; P Gauthier; M Pugnière; F Roquet; A Pèlegrin; I Navarro-Teulon
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

4.  A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs.

Authors:  R A Spooner; F Friedlos; K Maycroft; S M Stribbling; J Roussel; J Brueggen; B Stolz; T O'Reilly; J Wood; A Matter; R Marais; C J Springer
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.